Fundraising Fox
/People
Sign in

Quin Wills

Founder

Founder/CSO at Ochre Bio

United Kingdom

FoundedOchre Bio · YC

Find your path to Quin

11,472 people in our graph share verified history with Quin — schools, employers, funds. One of them is your warm intro.

Nessan BerminghamunlockedQuin: together at Ochre Bio (2022–2026)
Quin: together at Ochre Bio
×3Quin: together at Novo Nordisk
×3Quin: together at YC W20

About

Quin Wills is a physician whose academic training spans genetics, mathematics and computational biology, capped by a doctorate in systems genomics earned across Oxford and Cambridge. He previously launched a liver-focused drug genomics venture, helped lead Oxford's single-cell genomics consortium, and established the Cellular and Systems Genomics function at metabolic-disease biopharma Novo Nordisk.

Likely email· guessed from name + firm domain, not firm-published

Founder/CSO at Ochre BioYC W20

Intro paths

YC

Quin went through Y Combinator (Winter 2020) — any YC alum in your network can reach them through the YC community.

→

In turn, Quin can intro founders to Ochre Bio's investors below.

Ochre Bio's investors · 22

Acequia Capital (AceCap)Seattle · $100K – $5M checksAgrolimen VenturesApollo Health VenturesBerlin · since 2021BackedLondon · $500K – $5M checksBeast VenturesHong KongBiovergeSan FranciscoBoxOne VenturesMontréal · $500K checksCalm VenturesSan FranciscoCoastCapViennaEntrepreneur FirstBengaluru · $1M – $7M checksExpaWest Hollywood · $250K – $3M checksFAST — by GETTYLABSan Francisco · $100K checksFrialeNashville · $100K – $600K checksGaingelsNew York · $200K – $500K checksHoxton VenturesLondon · $500K – $5M checksKhosla VenturesMenlo Park · $5K – $50M checks · since 2022Lifeforce CapitalChevy Chase · $500K – $5M checks · since 2022Nadav RosenbergCanterburyNorrsken VCStockholm · $1.1M – $3.2M checksPathway BioventuresChicagoSelvedge VentureLondonY CombinatorSan Francisco · $500K checks · since 2020

Co-founders at Ochre Bio

JOJack O'Meara
Jack O'MearaFounding CEO

Experience

  1. Ochre BioFounder and CEOcurrent2025 — present
  2. Ochre BioFounder and CSO2019 — 2025Oxford, Taipei, New York City
  3. Novo NordiskHead of Cellular and Systems Genomics, Novo Nordisk Research Centre Oxford2017 — 2019Oxford
  4. University of Oxford (WTCHG, WIMM)Career Development Fellow (Single Cell Genomics)2014 — 2017Oxford, United Kingdom
  5. Mayo ClinicPostdoctoral Research Fellow (Pharmacogenomics)2012 — 2013
  6. SimuGenCo-founder and CSO2005 — 2011London, Kuala Lumpur
  7. University College LondonResearch Scientist2002 — 2003London, United Kingdom

Skills & more

Drug DiscoveryDrug DevelopmentGenomicsComputational BiologyBiotechnologyMolecular BiologyIn VitroEx Vivo

From Quin's professional profile.

Frequently asked questions

Who is Quin Wills?
Quin Wills is a physician whose academic training spans genetics, mathematics and computational biology, capped by a doctorate in systems genomics earned across Oxford and Cambridge. He previously launched a liver-focused drug genomics venture, helped lead Oxford's single-cell genomics consortium, and established the Cellular and Systems Genomics function at metabolic-disease biopharma Novo Nordisk.
Where does Quin Wills work?
Quin Wills is Founder/CSO of Ochre Bio.
What companies did Quin Wills found?
Quin Wills founded Ochre Bio.
Where did Quin Wills go to school?
Quin Wills studied at University of Oxford (DPhil, Statistical Genomics); University of Oxford (MSc, Applied and Computational Mathematics); University of Cambridge (MPhil, Computational Biology).

Founder mafias

Same school

Shared employers